Whit Bernard, Metsera CEO

Ex­clu­sive: Met­sera CEO on what it takes to build an obe­si­ty biotech in 2025

Met­sera, one of the few biotechs to com­plete an IPO this year, is mak­ing its best ef­fort to catch up to the obe­si­ty drug gi­ants …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.